Your healthcare news library

Archive for November 30, 2012

研究称:大多数双乳切除手术没有必要!

对许多乳腺癌患者来说,是否接受双乳房切除术是一个困难的决定。然而,一项研究称,70%接受双乳房切除术的女性其实不需要做该手术,研究人员担心这是对乳腺癌患者的过度治疗。

这项研究将在有美国临床肿瘤学会主办的优质治疗研讨会上发表。研究涉及了1446名妇女,她们的乳腺癌已得到成功治疗,没有复发。研究人员发现,有20%的妇女双乳都被切除。

许多接受双乳切除手术的妇女,因为担心自己另一侧的乳房也患乳腺癌,所以接受了这种可怕的手术。事实上,有90%的乳腺癌患者都在为自己另一侧的健康乳房担心。研究人员说,一侧乳房患癌并不会影响另一侧乳房患癌症的风险。

研究人员认为,双乳切除术应在非常特殊的情况进行。如有2个或2个以上的直系亲属有此家族病史,像母亲,姐妹或女儿患乳腺癌或卵巢癌的妇女,可以考虑双乳切除术。

同样,BRCA-1和BRCA-2基因突变检测结果呈阳性的女性也需要考虑双乳切除术。因为这些突变大大提高了她们另一侧乳房也患癌症的风险。

然而,没有这些特殊情况的妇女,接受双乳切除术很可能矫枉过正。

双乳切除手术还伴随着一系列并发症,导致患者更难恢复。有些妇女还需要忍受放疗和化疗的折磨,这将进一步延缓她们的治疗。

近日,名人莎朗·奥斯本登上头条新闻,她于本月初宣布,将接受双乳切除手术。她对《HELLO》杂志说,当她发现自己携带容易患乳腺癌的基因时,就“不假思索地”做了这个决定。

医药日报发布。

用力咳嗽血管爆 眼周長出”紫斑蝶”

咳嗽怎麼會這麼嚴重,台中有個女大生,咳嗽咳到眼睛周圍長出紫斑,就好像是一隻紫色班蝶停在上面。醫生說,這叫做號哭型紫斑症,可能是她咳嗽太用力,造成血管出血,才會變成紫斑。

張姓女大生皮膚光滑、臉蛋清秀,笑起來甜美動人,但在之前,他的臉卻是長這樣,眼睛周圍,出現一點一點紅色斑點,遠看就像,一隻紫色斑蝶停在上面,模樣 嚇人。不只眼睛出現紫色斑點,就連耳朵也有,女大生嚇壞了,一度以為自己罹患血液腫瘤,經醫生診斷後,才發現這叫做,號哭型紫斑症,屬於皮膚疾病。當時女 大生,就是因為感冒,用力咳嗽,壓力過大,造成皮下血管破裂,血液外流,最近感冒的人多,醫生提醒,咳嗽不要太用力,才不會咳到血管出血。

 cts

台灣老得快! 4年後老人比小孩多

台灣真的老了嗎,經建會最新人口統計顯示,人口老化加速、生育率下降,四年後國內老化指數將飆破百分之一百。也就是說,屆時老年人口將比幼年人口還要多,人口紅利沒了,台灣養老的負擔越來越沉重。

cts

自製洋蔥殺蟑藥

家裡如果出現小強,真的讓人很頭痛。到底該買哪種殺蟑藥才有效呢?其實有個小秘方,花個20塊錢,買顆洋蔥、麵粉、奶粉、砂糖和硼酸粉混合,就能做出殺蟑藥,而且,還能使用到半年的時間,今天的生活大百科就來教您,怎麼做滅蟑藥。

一團麵粉揉啊揉,每一個婆婆媽媽們手忙得很,不是搓湯圓,是在做殺蟑螂的藥啊,這殺蟑藥如何DIY呢,首先就是要準備奶粉麵粉,一顆洋蔥砂糖一包,還有 大型藥房就買得到的硼酸粉一包,作法呢就是先把麵粉、硼酸粉,奶粉和砂糖先均勻的混合,接著把洋蔥切丁磨成泥,然後慮掉多餘的水份後,加進混合好的材料 裡,接著就是像揉麵粉一樣,揉成一團之後,再捏下一小塊一小塊,壓成扁圓形狀,這殺蟑藥就完成啦。

不過得要先陰乾一個星 期,殺蟑才會有效果,原理就在於,洋蔥跟奶粉的香氣會吸引蟑螂來吃,但是裡頭的硼酸粉,有脫水效果也有毒性,所以蟑螂食用之後會逐漸死去,如果覺得這還是 有點麻煩,那就來個簡單一點的,就是用一小湯匙的硼酸粉,加上一小杯的水,兩個混合在一起倒進瓶子裡,就能噴在牆角廚櫃裡,蟑螂的觸角碰到之後,一樣也有 殺蟑效果。

cts

Malaysia to register 5.1% real GDP growth this year: WB

KUALA LUMPUR, Nov 29 (Bernama) — Malaysia is expected to register real Gross Domestic Product (GDP) growth of 5.1 percent in 2012 and 5.0 percent in 2013, according to a new World Bank report.

The Malaysia Economic Monitor launched today, said propelled by domestic demand, the economy is likely to weather a weak global environment and grow robustly in the next year.

The report also noted that strengthening structural reforms is the key to ensuring the positive growth momentum carries into the medium-term.

It said as investments had been lifted by sectors linked to commodities, it would be important to increase productivity in other parts of the economy, especially services, which generate the bulk of jobs.

“To achieve long-term productivity improvements, Malaysia will need to accelerate implementation of reforms, as outlined in the government’s New Economic Model, to boost competition and capabilities in the economy,” it added.

The Malaysia Economic Monitor series provides an analytical perspective on the policy challenges facing Malaysia as it grows into a high-income economy.

The series also represents an effort to reach out to a broad audience, including policy-makers, private sector leaders, market participants, civil society and academia.

The report can be accessed at www.worldbank.org/malaysia.

Sinchew

IHH profit below consensus

IHH HEALTHCARE BHD

By RHB Research Institute

Fair Value: RM3.53

Outperform (maintained)

IHH’s third-quarter ended Sept 30 net profit of RM96.1mil (-19.1% year-on-year; +12.4% quarter-on-quarter) was below our and consensus expectations with nine-month core net profit of RM329.6mil accounting for 54% and 57% of our and consensus full-year estimates respectively.

Key variances were higher-than-expected nine-month depreciation and amortisation expense of RM293.3mil and RM50.5mil, compared with our full-year projection of RM311.8mil and RM43.1mil respectively, which we believe was mainly due to the opening of Mount Novena Hospital in end-July.

Excluding the sale of Novena’s medical suites amounting to RM1.21bil in the second quarter, third-quarter revenue of RM1.5bil came in flat quarter-on-quarter higher inpatient admissions (+1.3%) in Singapore due the opening of the new Mount Novena Hospital was offset by a 4.9% and 4.2% decline in inpatient admissions in Malaysia and Turkey respectively.

We believe this was mainly due to the Hari Raya holiday season and the Hungry Ghost Festival in Malaysia as well as the summer season in Turkey, which typically leads to a lower number of admissions, and a marginal decrease in complex treatment procedures.

This coupled with a RM23.9mil earnings before interest, taxes, depreciation, and amortisation (EBITDA) loss for the new Mount Novena hospital and a higher depreciation expense led to a 12.4% decline in third-quarter core net profit.

Despite remaining in the red for the quarter, EBITDA losses of the new Mount Novena Hospital continues to narrow to RM23.9m in the third quarter (from RM28.3mil in the preceding quarter) as a progressive ramp-up in operations helped offset against overhead expenses incurred in newly opened areas.

According to management, inpatient flow has improved to more than 500 admissions in the third quarter (from about 200 in the second quarter) and plans to turn operations EBITDA positive by mid-2013 remains intact.

The risks include: 1) a significant increase in medical insurance premiums, which could result in lower demand; 2) lower-than-expected patient numbers, if there is a serious disease outbreak (such as SARS or swine flu); 3) weaker-than-expected earnings from overseas operations; and 4) slower-than-expected turnaround in new hospitals.

We reduced our financial year 2012 (FY12) to FY14 earnings forecasts by 9.3% to 20.7% after increasing our FY12 to FY14 depreciation and amortisation expense by 4.5% to 35.2% per year and 77.4% per annum respectively.

Despite the cut in our numbers, we maintain our “outperform” call on IHH with an unchanged sum-of-parts fair value of RM3.53.

GENTING PLANTATIONS BHD

By Kenanga Research

Underperform (downgraded)

Target price: RM8.30

GENTING Plantations’ first nine months period of the financial year 2012 (FY12) core net profit of RM240mil came in below the consensus but was broadly within our expectations.

It made up only 65% of the consensus’ FY12 forecast of RM371mil but was higher at 72% of our forecast of RM332mil.

We believe that the consensus may have overestimated the crude palm oil (CPO) price performance in the third quarter of FY12, which had weakened from September onwards due to an inventory surge.

Note that we have lowered our FY12 CPO price estimate to RM2,975 per tonne in our plantation sector update report on Oct 11.

There were no dividend announced as expected.

Year-on-year, the nine-month core net profit declined 30% to RM240mil as the average CPO price fell 8% to RM3,060 per tonne while the fresh fruit bunch (FFB) volume dropped by 7% to 932,071 tonne.

Cost of production is estimated to have increased by 15% due to the higher wage and fertiliser costs.

Quarter-on-quarter, the third-quarter core net profit jumped 27% to RM95mil as the impact of the FFB volume jump (38% higher to 380,815 tonnes) outpaced that of lower CPO prices (11% lower to RM2,858 per tonne).

The CPO price outlook has deteriorated for both the fourth quarter and the calendar year 2013.

With the cargo surveyors’ exports data for the first 25 days of November showing a decline by around 2%, we see a higher possibility now of Malaysian Palm Oil Board’s November inventory level registering another record high.

Our FY12 to FY13 estimated (FY13E) core net profit have been cut by 5% to 8% to RM313mil to RM381mil.

Our FY12E CPO price assumption has also been cut to RM2900 per tonne (from RM2975 per tonne) given the worse-than-expected CPO prices so far in the fourth quarter.

FY13E average CPO price assumption has been lowered to RM2850 per tonne (from RM3000 per tonne).

We have downgraded the stock to “underperform”. The fourth-quarter earnings could disappoint even more.

Note that the fourth-quarer average CPO price has been weak so far at RM2266 per tonne (21% lower quarter-on-quarter).

We have reduced our target price to RM8.30 (from RM9 previously) based on an unchanged forward price-to-earnings ratio of 16.5 times on the lower FY13E earnings per share of 50.3 sen (from 54.4 sen previously).

The risks involved would be better-than-expected CPO prices.

The Star

Spot legal cigarettes with their lines

SINGAPORE: From March next year, all cigarettes sold in Singapore must have a new marking to show that they are not contraband or smuggled goods.

Besides the letters “SDPC”, which stand for Singapore Duty-Paid Cigarette, there will be a series of vertical bars around the cigarette stick.

Cigarettes with the extra feature can be sold from December 1. From March 1, cigarettes without the new marking will be considered duty-unpaid and illegal.

This is to give manufacturers and retailers time to phase in the revised mark.

Singapore Customs said on Thursday that the new feature will make it easier to tell the difference between duty-paid cigarettes and contraband cigarettes, when it conducts checks to curb the selling, buying and possession of contraband cigarettes.

Those who bring in cigarettes from overseas for their own consumption have to declare them at the Customs Red Channel, as well as pay the duty and Goods and Services Tax (GST).

They should also keep the receipt as proof of payment.

(Photo: Singapore Customs)
CNA/xq

Tag Cloud